As of May 27, 2025, the Astonea Labs IPO is open for subscription, with the offering scheduled to close on May 29, 2025. The IPO comprises a fresh issue of 27.90 lakh equity shares, aiming to raise ₹37.67 crore. The price band has been set between ₹128 and ₹135 per share, with a minimum application of 1,000 shares, amounting to ₹1,35,000 at the upper price band. The shares are expected to list on the BSE SME platform on June 3, 2025.
As of now, detailed subscription figures for the Astonea Labs IPO are not publicly available. Investors can monitor live subscription status updates through platforms like Chittorgarh and InvestorGain, which track real-time data across various investor categories. The IPO's allotment status is anticipated to be finalized on May 30, 2025, with refunds and credit of shares to Demat accounts expected by June 2, 2025. Monitoring these figures can offer insights into investor demand and market sentiment during the subscription period. For more details, visit the Astonea Labs IPO page.
Subscription Status of Astonea Labs IPO (Day Wise)
The IPO subscription number shows how much demand there is for an IPO.
For mainboard IPOs, the subscription period lasts for 3 working days, while SME IPOs remain open for a longer period of 4-5 working days.
Formula to calculate Subscription Status:
Subscription = (Total Number of Bids Received) ÷ (Total Number of Shares Offered)
Day-Wise Subscription Table
Day
| QIB
| NII
| Retail
| Total Subscription
|
Day 1
| NA
| NA
| NA
| NA
|
Day 2
| NA
| NA
| NA
| NA
|
Day 3
| NA
| NA
| NA
| NA
|
Additional Read: How to Apply for Astonea Labs IPO?
How to Check IPO Subscription Data?
To keep track of the IPO's demand, follow these steps to track bids on both the NSE and BSE platforms:
Check out the following steps to track bids on NSE:
Visit the NSE India website.
Click on “IPO” and find Astonea Labs IPO.
Click on NSE Bid Details or Consolidated Bid Details from the drop-down menu under Category.
Check out the following steps to track bids on BSE:
Go to the BSE India website.
Look for Astonea Labs IPO.
Click on BSE Bid Details or Cumulative Bid Details.
Additional Read: Astonea Labs IPO Investment Guide: Objectives & Opportunities
Conclusion
Astonea Labs Ltd. operates as a contract manufacturer serving both pharmaceutical and cosmetic sectors, with a diverse portfolio that includes antibiotics, anti-cold medicines, and personal care products. The company’s focus on quality and compliance is reflected in its wide range of formulations and its adherence to industry standards. Additionally, Astonea Labs markets its own brands within India and exports products internationally, indicating a multifaceted business approach.
The planned IPO aims to support various growth initiatives, including expanding manufacturing capacity and enhancing marketing efforts. Financial data shows steady growth in assets, revenue, and net worth, while borrowings have increased to fund expansion. These factors together provide insight into the company’s operational scale and financial structure, offering potential investors a detailed view of its current position within the healthcare and personal care manufacturing industry.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Astonea Labs IPO.